Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19

The outbreak of novel coronavirus disease 2019 (COVID-19) has exacted a disproportionate toll on cancer patients. The effects of anticancer treatments and cancer patients’ characteristics shared significant responsibilities for this dismal outcome; however, the underlying immunopathological mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitali, Letizia, Merlini, Alessandra, Galvagno, Federica, Proment, Alessia, Sangiolo, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599827/
https://www.ncbi.nlm.nih.gov/pubmed/36289890
http://dx.doi.org/10.3390/biomedicines10102628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599827/
https://www.ncbi.nlm.nih.gov/pubmed/36289890
http://dx.doi.org/10.3390/biomedicines10102628

Ejemplares similares